NFKB1 and colitis: Exosome-like nanoparticles carrying curcumin and derived from Curcuma longa limit DSS-induced colitis development in mice by suppressing NF-κB activation and by increasing Treg cell and regulatory dendritic cell expansion in the colonic mucosa [113].